Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
TAK-272
Takeda
Renal Impairment
1 trial -
TAK-279
Takeda
Hepatic Impairment
1 trial -
TAK-279
Takeda
Renal Impairment
1 trial -
TAK-954
Takeda
Hepatic Impairment
1 trial -
TAK-954
Takeda
Renal Impairment
1 trial -
TD-4208
Theravance Biopharma Ireland Umited
Hepatic Impairment
1 trial -
TD-4208
Theravance Biopharma Ireland Umited
Renal Impairment
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Renal Impairment
1 trial -
Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)
Spero Therapeutics
Renal Impairment
1 trial -
Teduglutide
Takeda
Hepatic Impairment
1 trial -
Telotristat Ethyl
LEXICON PHARMACEUTICALS, INC.
Hepatic Impairment
1 trial -
VIR-2218
Vir Biotechnology
Hepatic Impairment
1 trial -
VIR-2218
Vir Biotechnology
Renal Impairment
1 trial -
Vadadustat
Akebia Europe Limited
Hepatic Impairment
1 trial -
Visual Sputum Suctioning System
The First People's Hospital of Lianyungang
Ineffective Airway Clearance
1 trial -
Vortioxetine
Takeda
Severe Hepatic Impairment
1 trial -
Yimitasvir Phosphate
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Hepatic Impairment
1 trial -
Yimitasvir Phosphate Capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Renal Impairment
1 trial -
belapectin
GALECTIN THERAPEUTICS INC
Hepatic Impairment
1 trial -
lofexidine HCl
BRIGHT MINDS BIOSCIENCES INC.
Renally Impaired Subjects
1 trial -
lumacaftor 200 mg q12h + ivacaftor 250 mg q12h
Vertex Pharmaceuticals (Australia) Pty.
Hepatic Impairment
1 trial -
questionnaires
Cardiff Oncology
Anxiety
1 trial -
sotagliflozin
LEXICON PHARMACEUTICALS, INC.
Hepatic Impairment
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Hepatic Impairment
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources